Viral Therapy May Prove to Be a Transformational Addition to Immuno-Oncology

Stephen J. Russell, MD, PhD of Mayo Clinic explains why viral therapy may prove to be a transformational addition to immuno-oncology. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.